CEO: | Craig Jonathan Gulliford |
CFO: | Richard John Rees |
Chief Technology Officer: | Christopher Paul Hancock |
Executive Director: | David Gerard Woods |
Independent Non-Executive Director: | Ivonne Cantu |
Independent Non-Executive Director: | John Bradshaw |
Non-Executive Chairman: | Charles Spicer |
Non-Executive Dir: |
Address: | Creo House, Unit 2 Beaufort Park, Beaufort Park Way, Chepstow, Wales, United Kingdom , NP16 5UH |
Phone: | +44 (0) 1291 606005 |
Website: | http://creomedical.com/ |
Sector: | Health Care(LSE) |
Index: | FTSE AIM All-Share |
ISIN: | GB00BZ1BLL44 |
Currency | UK Pounds |
Share Price | 35.00p |
Change Today | -0.25p |
% Change | -0.71 % |
52 Week High | 48.10 |
52 Week Low | 23.25 |
Volume | 373,908 |
Shares Issued | 361.48m |
Market Cap | £126.52m |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
Strong Buy | 1 |
Buy | 0 |
Neutral | 0 |
Sell | 0 |
Strong Sell | 0 |
Total | 1 |
No dividends found |
Time | Volume / Share Price |
16:31 | 100,000 @ 34.63p |
16:27 | 56,000 @ 35.48p |
16:20 | 530 @ 35.45p |
16:11 | 200 @ 35.45p |
16:08 | 1,408 @ 35.50p |
CEO | Craig Jonathan Gulliford |
CFO | Richard John Rees |
You are here: research